Kidney Cancer Clinical Trial

Biomarkers of Renal Dysfunction in Neuroblastoma Survivors

Summary

The main purpose of this study is to learn more about biomarkers of kidney function in the blood and urine of neuroblastoma survivors. A biomarker is a biological molecule found in blood, urine, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease. A biomarker may be used to see how well the body responds to a treatment for a disease or condition.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosis of neuroblastoma between 0-18 years of age
< 21 years of age at time of study enrollment
Two or more years from completion of systemic chemotherapy and/or radiation therapy

Exclusion Criteria:

Patients treated with observation only
Patients with multiple primary cancers

Study is for people with:

Kidney Cancer

Estimated Enrollment:

28

Study ID:

NCT03947346

Recruitment Status:

Active, not recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Estimated Enrollment:

28

Study ID:

NCT03947346

Recruitment Status:

Active, not recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.